Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1998
11/11/1998EP0876369A1 2- 2- (2-HYDROXYETHYL)AMINO]ETHYL]-5- 2-METHYLAMINO)ETHYL]AMINO]INDAZOLO 4,3-gh]ISOQUINOLIN-6(2H)-ONE AS ANTITUMOR AGENT
11/11/1998EP0876365A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
11/11/1998EP0876362A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
11/11/1998EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998EP0876343A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases
11/11/1998EP0876337A2 New lh-rh antagonists with improved effectiveness
11/11/1998EP0876330A1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity
11/11/1998EP0876160A2 Ligand directed enzyme prodrug therapy
11/11/1998EP0876153A2 Medical use of proteases
11/11/1998EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998EP0876149A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase
11/11/1998EP0630412B1 Methods to profile and treat abnormal cells
11/11/1998CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation
11/11/1998CN1198673A Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
11/11/1998CN1198669A Use of aminoadamantane compound as immunoregulators
11/11/1998CN1198668A Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
11/11/1998CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
11/11/1998CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998US5834586 Dehydrodidemnin B
11/10/1998US5834508 Ketone derivatives
11/10/1998US5834507 Cytotoxic agents prepared from podophyllotoxin; antitumor and carcinogenic agents
11/10/1998US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998US5834486 Antiproliferative, antiprotozoa agents
11/10/1998US5834463 Condensed heterocyclic compounds, their production and use
11/10/1998US5834455 Photosensitizers for sensitizing cells
11/10/1998US5834442 Treatment of prostate cancer
11/10/1998US5834441 Introducing a genetic sequence into a host cell
11/10/1998US5834419 Chemokine binding protein and methods of use therefor
11/10/1998US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998US5834186 Regulatable RNA molecule
11/10/1998US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998CA2230986A1 Epo primary response gene 1, eprg1
11/05/1998WO1998049561A1 Inhibitors of nuclear protein/nuclear receptor interaction
11/05/1998WO1998049349A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049321A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998WO1998049302A1 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998049299A1 Leukemia associated genes
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049288A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
11/05/1998WO1998049198A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/05/1998WO1998049196A1 Calcitonin receptor-binding peptides
11/05/1998WO1998049184A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049165A1 CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO[2,3,4-kl] ACRIDINE RING SYSTEM
11/05/1998WO1998049157A1 Farnesyltransferase inhibiting quinazolinones
11/05/1998WO1998049146A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998WO1998049138A2 Vitamin d3 analogs with bis c-20 side chains
11/05/1998WO1998049129A1 Conjugated linolenic acid-based synthetic triglycerides
11/05/1998WO1998048845A1 Method of demarcating tissue
11/05/1998WO1998048838A1 Compounds
11/05/1998WO1998048837A1 Polyalkylene oxide-modified single chain polypeptides
11/05/1998WO1998048831A1 Leptin as an inhibitor of tumor cell proliferation
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048789A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998WO1998048630A1 Method of treating malignancies
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998037091A3 Modified retinoblastoma tumor suppressor proteins
11/05/1998WO1998033798A3 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
11/05/1998WO1998033527A3 Cancer immunotherapy with semi-allogeneic cells
11/05/1998WO1998031799A3 Polynucleotides and polypeptides encoding receptors
11/05/1998WO1998030593A3 Assay of histidine decarboxylase to detect cancer
11/05/1998DE19720151A1 Chimäre Oligonucleotide und ihre Verwendung Chimeric oligonucleotides and their use
11/05/1998DE19712541C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/05/1998CA2289454A1 Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
11/05/1998CA2289019A1 Calcitonin receptor-binding peptides
11/05/1998CA2288343A1 Secreted proteins and polynucleotides encoding them
11/05/1998CA2288306A1 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998CA2288238A1 Leptin as an inhibitor of tumor cell proliferation
11/05/1998CA2288154A1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways
11/05/1998CA2287862A1 Cytotoxic compounds: derivatives of the pyrido¬2,3,4-kl| acridine ring system
11/05/1998CA2287318A1 Pharmaceutical compositions of arglabin and arglabin derivatives
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875511A1 Demethylation process for preparing benzo[b]thiophenes
11/04/1998EP0875508A1 Method for the preparation of baccatin III and derivatives thereof from 10-deacetylbaccatin III
11/04/1998EP0874848A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
11/04/1998EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
11/04/1998EP0874846A1 Purine derivatives and processes for their preparation
11/04/1998EP0874838A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
11/04/1998EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998EP0874815A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof
11/04/1998EP0874814A1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
11/04/1998EP0874813A1 24-homo-26,27-hexafluoro-cholecalciferols
11/04/1998EP0874808A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
11/04/1998EP0874665A1 Hollow-tube brachytherapy device
1 ... 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 ... 2211